What Is BPC-157? The Body Protection Compound Explained for Researchers
- Durham Peptides
- 2 days ago
- 5 min read
BPC-157 body protection compound angiogenesis tissue repair research peptide Durham Peptides Canada
BPC-157 is one of the most-discussed research peptides in the world, and the reason is its breadth: across a large preclinical literature, it has been studied for tissue-repair effects spanning tendon, ligament, muscle, gut, and vascular models — a range unusual for a single compound. That versatility, combined with a robust body of animal research, has made BPC-157 a cornerstone of the healing and recovery research category. It's also one of the most frequently searched research peptides, period.
This article explains what BPC-157 is, where it comes from, the mechanisms it's studied for, and how it fits the recovery research landscape. For Canadian researchers, Durham Peptides carries BPC-157 10mg (currently subject to stock availability — use the product page's "Notify When Available" function). Nothing here is medical, dosing, or therapeutic guidance.
The Origin: A Fragment of a Gastric Protein
BPC-157 stands for Body Protection Compound-157. It's a synthetic peptide derived from a partial sequence of a protein found in human gastric juice — body protection compound. Researchers identified that this gastric protein appeared to have protective and reparative properties, and BPC-157 represents a stable 15-amino-acid fragment synthesized to study those properties in isolation.
This gastric origin is part of why so much early BPC-157 research focused on the gastrointestinal tract — gut-lining protection and repair — before the literature broadened to tendon, ligament, muscle, and vascular models. The compound's notable stability (including stability in gastric juice, unusual for a peptide) is one of its defining research characteristics.
The Molecular Basics
Durham Peptides' BPC-157 is a stable, well-characterized pentadecapeptide (15 amino acids):
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formula: C₆₂H₉₈N₁₆O₂₂
Molecular weight: ~1419.5 g/mol
CAS number: 137525-51-0
Common synonyms: Body Protection Compound-157, BPC 15, PL 14736, Bepecin
At 15 amino acids, BPC-157 is a mid-sized peptide — larger than the tetrapeptide Epithalon but much smaller than the 43-amino-acid TB-500 it's so often paired with.
Mechanism 1: Angiogenesis (Blood Vessel Formation)
The most studied mechanism behind BPC-157's reparative effects is angiogenesis — the formation of new blood vessels. Tissue repair depends heavily on blood supply: injured tissue needs new vasculature to deliver oxygen, nutrients, and repair cells. BPC-157 has been studied for upregulating angiogenic signaling, including pathways involving the VEGFR2receptor and nitric oxide (NO) signaling.
This angiogenic mechanism is the key conceptual distinction between BPC-157 and its frequent partner TB-500: BPC-157 is studied primarily for building the blood supply to support repair (angiogenesis), while TB-500 is studied primarily for cell migration (moving repair cells to the injury site). The two complementary mechanisms are the basis for combining them — see BPC-157 vs TB-500.
Mechanism 2: The Gut-Brain and Healing Axis
Reflecting its gastric origin, BPC-157 has an extensive literature in gastrointestinal models — studied for its investigated protective effects on the gut lining and for influence on the gut-brain axis. This is one of the more distinctive research threads, less prominent in other recovery peptides.
Mechanism 3: Tendon, Ligament, and Muscle Models
The research thread that drives much of BPC-157's popularity is its study in
musculoskeletal repair — tendon, ligament, and muscle models. Preclinical work has examined its investigated effects on tendon-to-bone healing, fibroblast function, and the recovery of connective tissue, areas of strong interest in sports-science and orthopedic research contexts.
Mechanism 4: Other Research Threads
Additional areas of BPC-157 investigation include its study in nerve-related models, anti-inflammatory pathways, and cytoprotection across various tissue types. The breadth of the preclinical literature is itself part of the BPC-157 research story — though it's worth noting honestly that the overwhelming majority of this evidence is from animal models, with limited human clinical data to date.
What Researchers Examine
Angiogenesis and VEGFR2 / nitric oxide signaling pathways
Tendon, ligament, and muscle repair in preclinical models
Gastrointestinal protection and the gut-brain axis
Fibroblast function and connective-tissue recovery
Synergistic effects with TB-500 (the "Wolverine Stack" combination)
Where BPC-157 Fits in Recovery Research
BPC-157 anchors the healing and recovery research category alongside TB-500. The two are frequently studied together because their mechanisms are complementary rather than redundant:
BPC-157 → angiogenesis (blood-supply building), gut protection, tendon/ligament focus
TB-500 → cell migration (actin regulation), broad tissue repair
This complementarity is why Durham Peptides offers them both individually and pre-blended in the Wolverine Stack, and why BPC-157 also appears in the multi-peptide Glow Blend alongside GHK-Cu. For the category overview, see Healing & Recovery Peptides Explained; for the foundational peptide primer, see What Are Peptides?.
Quality and Storage
Durham Peptides' BPC-157 is supplied as a 10mg lyophilized peptide, Janoshik-verified to ≥99% purity by HPLC with mass-spec identity confirmation, 100% synthetically manufactured (vegan). Storage: 2–8°C, protected from light and moisture; reconstitute in bacteriostatic water. See How to Read a Janoshik COA, Vegan Peptides, and the peptide calculator for reconstitution math.
Frequently Asked Questions
What is BPC-157? A synthetic 15-amino-acid peptide derived from a protein in gastric juice (Body Protection Compound), studied for tissue repair through angiogenesis, gut protection, and musculoskeletal-recovery pathways.
What does BPC-157 stand for? Body Protection Compound-157, reflecting its origin from a protective protein identified in gastric juice.
What is BPC-157 studied for? Primarily angiogenesis (blood-vessel formation), tendon/ligament/muscle repair, and gastrointestinal protection in preclinical models. Most evidence is from animal studies.
How is BPC-157 different from TB-500? BPC-157 is studied primarily for angiogenesis
(building blood supply) and gut protection; TB-500 is studied primarily for cell migration (actin regulation). Their complementary mechanisms are why they're often combined.
Is there human clinical data on BPC-157? The large majority of BPC-157 research is from animal/preclinical models, with limited human clinical data to date — which is part of why it remains a research compound.
Where can I buy BPC-157 in Canada? Durham Peptides carries BPC-157 10mg for laboratory use only, subject to stock availability (use the "Notify When Available" function). See Buy BPC-157 in Canada.
Final Thoughts
BPC-157 earned its place at the center of recovery research through the sheer breadth of its preclinical literature — angiogenesis, gut protection, and musculoskeletal repair all
studied under one compound. Its gastric origin and notable stability make it mechanistically distinctive, and its complementary relationship with TB-500 makes it a foundation of combination tissue-repair research. The honest caveat is that the evidence base is overwhelmingly preclinical, so BPC-157 is best understood as a compound of strong research interest rather than a proven intervention.
For Canadian researchers, Durham Peptides supplies BPC-157 10mg at C$55.00, subject to availability. For its frequent research partner, see What Is TB-500?; for the head-to-head, see BPC-157 vs TB-500; and for the buying decision, see Buy BPC-157 in Canada.
Selected Research References
Sikiric P, Seiwerth S, Rucman R, et al. Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Current Pharmaceutical Design. 2011;17(16):1612-1632. https://pubmed.ncbi.nlm.nih.gov/21548867/
Chang CH, Tsai WC, Lin MS, et al. The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration. Journal of Applied Physiology. 2011;110(3):774-780. https://pubmed.ncbi.nlm.nih.gov/21030672/
Seiwerth S, Brcic L, Vuletic LB, et al. BPC 157 and Blood Vessels. Current Pharmaceutical Design. 2014;20(7):1121-1125. https://pubmed.ncbi.nlm.nih.gov/23782145/
Sikiric P, Seiwerth S, Rucman R, et al. Brain-Gut Axis and Pentadecapeptide BPC 157. Current Neuropharmacology. 2016;14(8):857-865. https://pubmed.ncbi.nlm.nih.gov/27138887/
All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.
